Germany· DE-A57-77a2cbd7bbaa9fa6
Hirudoid
A medicinal product containing chondroitin polysulfate, registered in Germany by Stada Gmbh.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Chondroitin Polysulfate
- Manufacturer
- Stada Gmbh
- Country
- Germany (DE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- August 5, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chondroitin polysulfate in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainCONDRODIN 400 CAPSULAS DURASLaboratorio Reig Jofre, S.A.
- SwitzerlandCondrosulf 400
- CzechiaCONDRODINLaboratorio Reig Jofré S.A., Barcelona
- PolandCartexanDelfarma Sp. z o.o.
- FinlandCartexanOrifarm Oy
- Japanコンドロイチン硫酸エステルナトリウム
- FranceCHONDROSULF 800 mg, compriméIBSA PHARMA SAS
- United KingdomGepan Instill 0.2% bladder instillation pre-filled syringePurple Orchid Health Ltd
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Cartexan, Condrosulf
- Belgium · Hirudoid
- Czechia · Condrodin, Condrosulf
- Denmark · Hirudoid
- Spain · Condrodin, Condroitín Sulfato Kern Pharma
- Finland · Cartexan, Cartexan Laboratorio Reig Jofre, S.A.
- France · Chondrosulf, Chondrosulf Sans Sucre Édulcoré Au Xylitol
- United Kingdom (Northern Ireland) · Hirudoid, Hirudoid Gel
- Greece · Condromed
- Hungary · Cartexan, Condrosulf
- Iceland · Hirudoid
- Italy · Condral, Condrosulf
- Luxembourg · Hirudoid
- Netherlands · Hirudoid
- Norway · Hirudoid
- Poland · Cartexan, Condromed
- Portugal · Hirudoid, Ossin
- Romania · Hirudoid
- Sweden · Hirudoid
- Slovakia · Condrosulf, Hirudoid Forte
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/20beb71f-1b9d-4fe2-828c-6d6e2f0f65b2 GET /v1/drugs/20beb71f-1b9d-4fe2-828c-6d6e2f0f65b2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Cutaneous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Chondroitin Polysulfate",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about chondroitin polysulfate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.